Clinical Trial Update: Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating moxifloxacin for uncomplicated pelvic inflammatory disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Inflammatory Disease

Drugs mentioned

• Avelox (moxifloxacin)

Snippet

Sponsor: Bayer | Conditions: Pelvic Inflammatory Disease | Phase 3 | Status: COMPLETED